Combination GLP-1 receptor agonist and SGLT2 inhibitor therapy versus GLP-1 receptor agonist monotherapy on arrhythmia outcomes in non-diabetic obese patients: A real-world time-dependent analysis
Combination GLP-1 receptor agonist and SGLT2 inhibitor therapy versus GLP-1 receptor agonist monotherapy on arrhythmia outcomes in non-diabetic obese patients: A real-world time-dependent analysis. // International Journal of Cardiology Cardiovascular Risk and Prevention. – URL: https://www.sciencedirect.com/science/article/pii/S277248752600111X?dgcid=rss_sd_all
Combination GLP-1 receptor agonist and SGLT2 inhibitor therapy versus GLP-1 receptor agonist monotherapy on arrhythmia outcomes in non-diabetic obese patients: A real-world time-dependent analysis. International Journal of Cardiology Cardiovascular Risk and Prevention. https://www.sciencedirect.com/science/article/pii/S277248752600111X?dgcid=rss_sd_all
“Combination GLP-1 receptor agonist and SGLT2 inhibitor therapy versus GLP-1 receptor agonist monotherapy on arrhythmia outcomes in non-diabetic obese patients: A real-world time-dependent analysis.” International Journal of Cardiology Cardiovascular Risk and Prevention.
@article{article94045,
title = {Combination GLP-1 receptor agonist and SGLT2 inhibitor therapy versus GLP-1 receptor agonist monotherapy on arrhythmia outcomes in non-diabetic obese patients: A real-world time-dependent analysis},
journal = {International Journal of Cardiology Cardiovascular Risk and Prevention},
url = {https://www.sciencedirect.com/science/article/pii/S277248752600111X?dgcid=rss_sd_all}
}
Abstract Background Macrophage polarisation plays a crucial role in sepsis‐associated inflammatory responses; however, the underlying molecular regulatory mechanisms remain to be further explored. Aim This study aimed to explore the...